⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL457593 | 0.83 | — | — | |
| SCHEMBL58401 | 0.82 | GABRA1 (0.33) | — | |
| SCHEMBL10458945 | 0.81 | TAAR1 (0.31) | — | |
| SCHEMBL27460611 | 0.80 | GABRA1 (0.32) | — | |
| SCHEMBL62016 | 0.78 | — | — | |
| SCHEMBL455192 | 0.78 | — | — | |
| SCHEMBL29042076 | 0.78 | — | — | |
| SCHEMBL18322544 | 0.78 | — | — | |
| SCHEMBL11716554 | 0.78 | — | — | |
| SCHEMBL1954797 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181148-A | 'on-off' type fluorescent probe, preparation method and application thereof | 东北农业大学 | 2022-03-15 | — | — | CN | claimed |
| EP-1401829-B1 | NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS | MICROBIOTIX INC (US) | 2012-08-22 | — | — | EP | claimed |
| CN-101287734-B | 2-amino-7, 8-dihydro-6H-pyrido [4,3-d ] pyrimidin-5-ones | NOVARTIS AG | 2011-07-20 | — | — | CN | claimed |
| EP-1928875-B1 | 2-amino-7,8-dihydro-6H-pyrido(4,3-d)pyrimidin-5-ones, process for their preparation and pharmaceutical compositions containing the same | NOVARTIS AG (CH) | 2011-06-29 | — | — | EP | claimed |
| CN-101983191-A | Oxim derivatives as hsp90 inhibitors | TAKEDA PHARMACEUTICAL | 2011-03-02 | — | — | CN | claimed |
| EP-2252595-A1 | OXIM DERIVATIVES AS HSP90 INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2010-11-24 | — | — | EP | claimed |
| US-7671059-B2 | 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones | NOVARTIS AG (CH) | 2010-03-02 | — | — | US | claimed |
| US-20090305998-A1 | HSP90 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-10 | — | — | US | claimed |
| WO-2009097578-A1 | OXIM DERIVATIVES AS HSP90 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-08-06 | — | — | WO | claimed |
| CN-101287734-A | 2-amino-7, 8-dihydro-6H-pyrido [4, 3-d ] pyrimidin-5-ones | NOVARTIS AG (CH) | 2008-10-15 | — | — | CN | claimed |
| EP-1928875-A1 | 2-AMINO-7,8-DIHYDRO-6H-PYRIDOÝ4,3-D¨PYRIMIDIN-5-ONES | Novartis AG (CH) | 2008-06-11 | — | — | EP | claimed |
| CN-101198596-A | 2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2008-06-11 | — | — | CN | claimed |
| EP-1885701-A2 | 2-AMINO-QUINAZ0LIN-5-ONES AS HSP90 INHIBITORS USEFUL IN TREATING PROLIFERATION DISEASES | Novartis Vaccines and Diagnostics, Inc. (US) | 2008-02-13 | — | — | EP | claimed |
| US-20070123546-A1 | 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones | CHIRON CORPORATION | 2007-05-31 | — | — | US | claimed |
| WO-2007041362-A1 | 2-AMINO-7,8-DIHYDRO-6H-PYRIDO[4,3-D] PYRIMIDIN-5-ONES | NOVARTIS AG (CH) | 2007-04-12 | — | — | WO | claimed |
| US-20070027150-A1 | 2-Amino-quinazolin-5-ones | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2007-02-01 | — | — | US | claimed |
| WO-2006113498-A2 | 2-AMINO-QUINAZ0LIN-5-ONES AS HSP90 INHIBITORS USEFUL IN TREATING PROLIFERATION DISEASES | NOVARTIS VACCINES AND DIAGNOSTICS INC. (US) | 2006-10-26 | — | — | WO | claimed |
| EP-1199310-B1 | PROCESS FOR THE PREPARATION OF CONDENSED PHOSPHORIC ESTERS | DAIHACHI CHEM IND (JP) | 2003-11-05 | — | — | EP | claimed |
| US-20030114445-A1 | N3-substituted 6-anilinopyrimidines and methods to treat-Gram-positive bacterial and mycoplasmal infections | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-06-19 | — | — | US | claimed |
| WO-2003011297-A1 | N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS | UNIVERSITY OF MASSACHUSETTS (US) | 2003-02-13 | — | — | WO | claimed |